drugset / Trial / NCT01316861

Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

NCT01316861

Phase 3 Completed 79 enrolled EMS
RandomizedParallel-groupTriple-blindTreatment

Summary

The Purpose of This Study is to Evaluate the Efficacy and Safety of Acarbose in Type 2 Diabetic Patients Using Two Different Formulations of Acarbose 50mg.

Timeline

Start
2012-09
Primary completion
2013-03
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acarbose Unknown 50 mg Oral